A prospective phase II single-arm study and predictive factor analysis of irinotecan as third-line treatment in patients with metastatic gastric cancer
Article in Therapeutic Advances in Medical Oncology (January 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Multivariate prognostic index and triplet regimen efficacy predictive index in locally advanced and metastatic gastric cancer: pooled analysis from three clinical trials using individual patient data
Article in Therapeutic Advances in Medical Oncology (January 2024)
Tectorigenin suppresses the viability of gastric cancer cells in vivo and in vitro
Article in Quality Assurance and Safety of Crops & Foods (September 2023)